ARCA biopharma, Inc.
(NasdaqGM: ABIO) After Hours:
0.00 N/A (N/A) 13:00
| Last Trade: | 3.45 |
|---|
| Trade Time: | 4 Sep 05:59 |
|---|
| Change: | 0.01 (0.29%) |
|---|
| Prev Close: | 3.44 |
|---|
| Open: | 3.51 |
|---|
| Bid: | 2.02 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Day's Range: | 3.40 - 3.54 |
|---|
| 52wk Range: | 2.21 - 9.23 |
|---|
| Volume: | 41,044 |
|---|
| Avg Vol (3m): | 93,933 |
|---|
| Market Cap: | 30.48M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.93 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Competitive Technologies: Short Squeeze Coming or Another Leg Down?at Seeking Alpha(Wed 25 Aug)
- ARCA BIOPHARMA, INC. FinancialsEDGAR Online Financials(Sun 15 Aug)
- ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed 11 Aug)
- ARCA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Thu 27 May)
- GLG Gains On Buyout Newsat Forbes(Tue 18 May)
- [video] Today's Big Gainers: GLG, VRAD, ABIOat Forbes.com(Tue 18 May)
- InfoLogix, Netlist: Midday Volume Playsat TheStreet.com(Tue 18 May)
- ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue 18 May)
- ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Fri 14 May)
- ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue 11 May)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
ARCA biopharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of genetically-targeted therapies for heart failure and other cardiovascular diseases in the United States.
View More